What is the address of GUISSET MEDICONSULT?

The registered office of GUISSET MEDICONSULT is located at Panoramalaan 2, 1650 Beersel.

Is GUISSET MEDICONSULT still active?

Yes. According to the CBE (18 September 2026) GUISSET MEDICONSULT is active, legal situation “Normale toestand”, started on 30 October 2021.

Is GUISSET MEDICONSULT registered on Peppol?

No, GUISSET MEDICONSULT is currently not registered on the Peppol network.

What is the enterprise number of GUISSET MEDICONSULT?

The enterprise number of GUISSET MEDICONSULT is BE0776706417.

When was GUISSET MEDICONSULT founded?

GUISSET MEDICONSULT was founded on 30 October 2021.

Who are the directors of GUISSET MEDICONSULT?

According to the 2025 annual accounts, the directors of GUISSET MEDICONSULT are: François Guisset.

Is GUISSET MEDICONSULT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 October 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GUISSET MEDICONSULT make in 2025?

GUISSET MEDICONSULT posted a profit after taxes of € 38,478 in financial year 2025.

What is the revenue of GUISSET MEDICONSULT?

As a small company, GUISSET MEDICONSULT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 66,162.

GUISSET MEDICONSULT (Private Limited) - Beersel

Dossier GUISSET MEDICONSULT, printed on 18 September 2026 from databakkes.be/en/0776706417/guisset-mediconsult. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

GUISSET MEDICONSULT from Beersel, company number BE0776706417, closed financial year 2025 with a result of € 38,478 after tax. For that financial year GUISSET MEDICONSULT recorded a gross margin of € 66,162 and equity of € 63,199. Compared with financial year 2024, the result moved from € 24,896 to € 38,478. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Growing

€ 63,199

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 38,478

▲ 55% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 39,027

▼ 68% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,000 paid out

78 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 21,215

▼ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 20,673

▼ 44% vs 2024

€ 16,514 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 470

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 558

▲ 249% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 119,942 Gross margin 2022: € 119,942 First fiscal year in the series	€ 100,129 Gross margin 2023: € 100,129 ▼ 17% vs 2022 (€ 119,942) Unfavourable step	€ 49,984 Gross margin 2024: € 49,984 ▼ 50% vs 2023 (€ 100,129) Unfavourable step	€ 66,162 Gross margin 2025: € 66,162 ▲ 32% vs 2024 (€ 49,984) Favourable step	▲ 32%
Profit after taxes	€ 80,330 Profit after taxes 2022: € 80,330 First fiscal year in the series	€ 65,181 Profit after taxes 2023: € 65,181 ▼ 19% vs 2022 (€ 80,330) Unfavourable step	€ 24,896 Profit after taxes 2024: € 24,896 ▼ 62% vs 2023 (€ 65,181) Unfavourable step	€ 38,478 Profit after taxes 2025: € 38,478 ▲ 55% vs 2024 (€ 24,896) Favourable step	▲ 55%
Equity	€ 85,330 Equity 2022: € 85,330 First fiscal year in the series	€ 150,512 Equity 2023: € 150,512 ▲ 76% vs 2022 (€ 85,330) Favourable step	€ 54,721 Equity 2024: € 54,721 ▼ 64% vs 2023 (€ 150,512) Unfavourable step	€ 63,199 Equity 2025: € 63,199 ▲ 15% vs 2024 (€ 54,721) Favourable step	▲ 15%
Total debts	€ 83,783 Total debts 2022: € 83,783 First fiscal year in the series	€ 67,592 Total debts 2023: € 67,592 ▼ 19% vs 2022 (€ 83,783) Favourable step	€ 158,831 Total debts 2024: € 158,831 ▲ 135% vs 2023 (€ 67,592) Unfavourable step	€ 52,379 Total debts 2025: € 52,379 ▼ 67% vs 2024 (€ 158,831) Favourable step	▼ 67%
Cash	€ 55,073 Cash 2022: € 55,073 First fiscal year in the series	€ 111,327 Cash 2023: € 111,327 ▲ 102% vs 2022 (€ 55,073) Favourable step	€ 120,847 Cash 2024: € 120,847 ▲ 9% vs 2023 (€ 111,327) Favourable step	€ 39,027 Cash 2025: € 39,027 ▼ 68% vs 2024 (€ 120,847) Unfavourable step	▼ 68%
Retained profit	€ 80,330 Retained profit 2022: € 80,330 First fiscal year in the series	€ 145,512 Retained profit 2023: € 145,512 ▲ 81% vs 2022 (€ 80,330) Favourable step	€ 49,721 Retained profit 2024: € 49,721 ▼ 66% vs 2023 (€ 145,512) Unfavourable step	€ 58,199 Retained profit 2025: € 58,199 ▲ 17% vs 2024 (€ 49,721) Favourable step	▲ 17%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 120,687 Dividend 2024: € 120,687 Unchanged (€ 0) Unchanged	€ 30,000 Dividend 2025: € 30,000 ▼ 75% vs 2024 (€ 120,687) Unchanged	▼ 75%
Bank debt	€ 69,057 Bank debt 2022: € 69,057 First fiscal year in the series	€ 53,120 Bank debt 2023: € 53,120 ▼ 23% vs 2022 (€ 69,057) Favourable step	€ 36,993 Bank debt 2024: € 36,993 ▼ 30% vs 2023 (€ 53,120) Favourable step	€ 20,673 Bank debt 2025: € 20,673 ▼ 44% vs 2024 (€ 36,993) Favourable step	▼ 44%
Balance sheet total	€ 169,114 Balance sheet total 2022: € 169,114 First fiscal year in the series	€ 218,103 Balance sheet total 2023: € 218,103 ▲ 29% vs 2022 (€ 169,114) Unchanged	€ 213,552 Balance sheet total 2024: € 213,552 ▼ 2% vs 2023 (€ 218,103) Unchanged	€ 115,578 Balance sheet total 2025: € 115,578 ▼ 46% vs 2024 (€ 213,552) Unchanged	▼ 46%

Key figures of GUISSET MEDICONSULT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GUISSET MEDICONSULT?

What happened at GUISSET MEDICONSULT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 38,478 (▲ 55% vs 2024). Source: NBB ↗
Oct 30, 2021 New establishment in Anderlecht. KBO
2021 François Guisset became a director. NBB
Oct 30, 2021 Start of the company according to the CBE. KBO

In short

From € 80,330 profit in 2022 to € 38,478 profit in 2025.

Paid € 55,170 in corporate taxes since 2022.

Best year ever: 2022, with € 80,330 profit.

Paid out € 150,687 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at GUISSET MEDICONSULT? We notify you, reason included.

Follow GUISSET MEDICONSULT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

François Guisset

GUISSET MEDICONSULT

Behind GUISSET MEDICONSULT is François Guisset.

See the full network in the app

Directors

According to the 2025 annual accounts

François Guisset

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Panoramalaan 2

1650 Beersel

2.323.905.016

Lennikse Baan 195 box 101

1070 Anderlecht

Active since 30 October 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0776.706.417
VAT number: BE 0776.706.417
Registered office: Panoramalaan 2, 1650 Beersel
Names & denominations: GUISSET MEDICONSULT · GUISSET
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 October 2021
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗